Study of Genetic Alzheimer's Disease Mutation Carriers in Preclinical Stages of the Disease 18F-Florbetaben Positron Emission Tomography Study

NCT02362880 · clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
32
Enrollment
OTHER
Sponsor class

Stopped On 15 January 2019, the sponsor decided to stop the study prematurely due to lack of patient recruitment because of supply problems with 18 F-Florbetaben.

Conditions

Interventions

Sponsor

Judit Pich Martínez